Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction
- 1 June 2016
- journal article
- clinical trial
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25 (6) , 568-575
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- From hypertension to heart failure: update on the management of systolic and diastolic dysfunctionAmerican Journal of Hypertension, 2003
- Heart FailureNew England Journal of Medicine, 2003
- Burden of Systolic and Diastolic Ventricular Dysfunction in the CommunityJAMA, 2003
- Heart Failure — An Epidemic of Uncertain ProportionsNew England Journal of Medicine, 2002
- Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST ElevationCirculation, 2001
- Freedom from congestion predicts good survival despite previous class IV symptoms of heart failureAmerican Heart Journal, 2000
- Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.JACC, 2000
- Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary SyndromeCirculation, 1999
- Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failureJACC, 1998
- Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarctionJACC, 1994